News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|October 1, 2021

Hypothyroidism: Goals, Challenges, and Special Populations

Author(s)Todd Frieze, MD, FACP, FACE

Guideline recommendations for treatment and goals of therapy in hypothyroidism, as well as challenges and special patient populations, are discussed.

Episodes in this series

EP. 1 Introduction: Optimizing Patient Management in Hypothyroidism

EP. 1 Introduction: Optimizing Patient Management in Hypothyroidism

EP. 2 Overview of Hypothyroidism

EP. 2 Overview of Hypothyroidism

EP. 3 Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

EP. 3 Clinical Manifestations, Implications and Diagnosis of Hypothyroidism

EP. 4 Hypothyroidism: Goals, Challenges, and Special Populations

EP. 4 Hypothyroidism: Goals, Challenges, and Special Populations

EP. 5 Patient Case: Hypothyroidism Diagnosis and Optimal Management

EP. 5 Patient Case: Hypothyroidism Diagnosis and Optimal Management

EP. 6 Hypothyroidism: Challenges in Optimal Patient Management

EP. 6 Hypothyroidism: Challenges in Optimal Patient Management

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

The psychology of needle phobia: Why it’s a bigger health challenge than we think

2025 state of claims: How much training is needed to implement an AI solution

Spooky science; safety tips from the ACEP; the surprising health perks of Halloween – Morning Medical Update

Baxter reports 5% revenue growth in Q3 as new CEO launches improvement effort

1 in 10 people report gluten sensitivity without celiac disease; Eli Lilly, Walmart partner to offer retail access to Zepbound; early-onset cancer and the workplace – Morning Medical Update

© 2025 MJH Life Sciences^®

All rights reserved.